Related Experiment Videos
Role of electrophysiologic evaluation in patients with ventricular arrhythmias
1Department of Medicine, Cedars-Sinai Medical Center 90048, USA.
Insights
Electrophysiologic testing is crucial for diagnosing and managing ventricular arrhythmias, especially in patients with heart disease. It helps identify high-risk individuals for life-threatening events.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Ventricular arrhythmias present a wide spectrum, from asymptomatic ectopy to cardiac arrest.
- Risk stratification is essential to identify patients prone to life-terminating events.
Purpose of the Study:
- To determine the role of electrophysiologic testing in evaluating patients with ventricular arrhythmias.
- To outline a risk stratification strategy for ventricular arrhythmias.
Main Methods:
- Review of clinical presentations and types of ventricular arrhythmias.
- Utilizing noninvasive evaluations like ECG, Holter monitoring, and echocardiography.
- Electrophysiologic testing for diagnosis, risk stratification, and management.
Main Results:
- Decision for testing depends on heart disease and arrhythmia type.
- Noninvasive methods aid risk stratification.
- Electrophysiologic testing is optimal for most ventricular tachyarrhythmias.
Conclusions:
- Electrophysiologic testing is the optimal method for diagnosing, risk-stratifying, and managing ventricular tachyarrhythmias.
- Risk stratification guides therapy to prevent symptoms and prolong life.
Abstract:
The decision to perform electrophysiologic testing in patients with ventricular arrhythmia should be based on the presence, if any, of underlying heart disease and the clinical type of ventricular arrhythmia. Clinical presentations range from asymptomatic premature ventricular complexes identified on routine surface ECG to out-of-hospital cardiac arrest. Ventricular arrhythmias range from benign monomorphic ventricular ectopy to polymorphic VT and ventricular fibrillation. The goal in evaluating patients with ventricular arrhythmia is to identify those at high risk of suffering a life-terminating arrhythmic event. Risk stratification should be based on history, physical examination, clinical data and the likelihood that anti-arrhythmic therapy will prevent symptoms and more importantly, prolong life. Noninvasive evaluation with routine surface ECG, Holter monitoring, signal-averaged ECG and echocardiography are valuable tools in the risk stratification process. However, electrophysiologic testing in most forms of ventricular tachyarrhythmia is the optimal means of diagnosing, risk stratifying and managing potentially life-threatening ventricular arrhythmias.